While yesterday the WHO authorized the emergency use of Sinopharm's Chinese vaccine, i.e. they found the vaccine good, today the European Commission did not renew its expiring contract with AstraZeneca, completely confusing the anti-vaccine and/or vaccine-skeptic strategy of the Hungarian left-liberal opposition.
"We did not renew the contract (with AstraZenaca) after June. We'll see what happens later," said the French commissioner in an interview with France Inter public radio.
The European Commission has not renewed its contract with AstraZeneca, which expires in June, said Thierry Breton, the EU Commissioner responsible for the internal market, on Sunday, a day after the European Union approved the purchase of 1.8 billion doses of the vaccine developed by Pfizer/BioNTech against the coronavirus until 2023. up to insurance contract.
Thierry Breton gave an evasive answer to the question that this means that no more AstraZeneca vaccines will permanently arrive in the European Union.
"This cannot be declared yet, they have to wait.
We have only just started (renewing the contracts with Pfizer/BioNTech), and we will renew them with others as well," said the commissioner. "We started with Pfizer because we are already working on the second stage, the second generation vaccines," he added. Ursula von der Leyen announced on Saturday that the new, third contract signed with the Pfizer/BioNTech companies stipulates the delivery of 900 million doses of the coronavirus vaccine with the possibility of buying another 900 million doses later in 2022 and 2023, and added that the European The Commission also plans to conclude additional contracts with other pharmaceutical manufacturers.
According to his previous information, in addition to ensuring protection against new variants of the coronavirus, the additional vaccine doses will also enable the vaccination of children and young people.
The European Commission has made it clear that it prefers messenger RNA-based (mRNA) vaccines, Pfizer and the American Moderna, because they have been proven effective against the South American and Brazilian variants of the coronavirus.
Thierry Breton already said in mid-April that the European Union will only contract with vaccine manufacturers that fulfill orders on time.
French Industry Minister Agnes Pannier-Runacher then indicated that the EU is unlikely to extend the contract with the Swedish-British pharmaceutical giant after Denmark stopped using AstraZeneca's vaccine completely, and in other countries its use was subject to age restrictions due to rare cases of blood clot formation. Last month, the European Commission initiated legal proceedings against AstaZeneca, because the British-Swedish manufacturer did not fulfill its agreed deliveries on time, the parties will meet before the court in Brussels on May 26.
Source MTI
Image: egeszsegkalauz.hu
